Search Results - "Beckham, Thomas H."

Refine Results
  1. 1
  2. 2

    Intracranial meningiomas: an update of the 2021 World Health Organization classifications and review of management with a focus on radiation therapy by Yarabarla, Varun, Mylarapu, Amrutha, Han, Tatiana J, McGovern, Susan L, Raza, Shaan M, Beckham, Thomas H

    Published in Frontiers in oncology (22-08-2023)
    “…Meningiomas account for approximately one third of all primary intracranial tumors. Arising from the cells of the arachnoid mater, these neoplasms are found…”
    Get full text
    Journal Article
  3. 3

    Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling by Beckham, Thomas H, Cheng, Joseph C, Lu, Ping, Marrison, S Tucker, Norris, James S, Liu, Xiang

    Published in PloS one (01-10-2013)
    “…The tumor suppressor PTEN is now understood to regulate cellular processes at the cytoplasmic membrane, where it classically regulates PI3K signaling, as well…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Acid ceramidase upregulation in prostate cancer: role in tumor development and implications for therapy by Liu, Xiang, Cheng, Joseph C, Turner, Lorianne S, Elojeimy, Saeed, Beckham, Thomas H, Bielawska, Alicja, Keane, Thomas E, Hannun, Yusuf A, Norris, James S

    Published in Expert opinion on therapeutic targets (01-12-2009)
    “…Bioactive sphingolipids, such as ceramide, sphingosine and sphingosine-1-phosphate are known bio-effector molecules which play important roles in various…”
    Get more information
    Journal Article
  8. 8

    Metastasis-directed therapy for oligometastasis and beyond by Beckham, Thomas H., Yang, T. Jonathan, Gomez, Daniel, Tsai, C. Jillian

    Published in British journal of cancer (05-01-2021)
    “…Metastasis-directed therapy (MDT)—local therapy that is intended to eradicate specific metastatic lesions—has hitherto been used with varying degrees of…”
    Get full text
    Journal Article
  9. 9

    Long-term survival in patients with metastatic head and neck squamous cell carcinoma treated with metastasis-directed therapy by Beckham, Thomas H., Leeman, Jonathan E., Xie, Peng, Li, Xiaolin, Goldman, Debra A., Zhang, Zhigang, Sherman, Eric, McBride, Sean, Riaz, Nadeem, Lee, Nancy, Tsai, C. Jillian

    Published in British journal of cancer (26-11-2019)
    “…Background Our objective was to evaluate the outcomes of metastatic head and neck squamous cell carcinoma (HNSCC) by disease burden with an emphasis on…”
    Get full text
    Journal Article
  10. 10

    Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials by Beckham, Thomas H, Elojeimy, Saeed, Cheng, Joseph C, Turner, Lorianne S, Hoffman, Stanley R, Norris, James S, Liu, Xiang

    Published in Expert opinion on therapeutic targets (01-05-2010)
    “…Ceramide accumulation has been shown to be a conserved mechanism of apoptosis initiation in normal physiological processes as well as in response to cancer…”
    Get more information
    Journal Article
  11. 11
  12. 12

    Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature by Beckham, Thomas H., Leeman, Jonathan, Jillian Tsai, Chiaojung, Riaz, Nadeem, Sherman, Eric, Singh, Bhuvanesh, Lee, Nancy, McBride, Sean, Higginson, Daniel S.

    Published in Head & neck (01-05-2019)
    “…Background Fanconi anemia (FA) is associated with an increased risk of developing head and neck squamous cell cancer (HNSCC) and presents a treatment dilemma…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18

    Excellent Outcomes with Surgery or Radiotherapy in the Management of Castleman Disease Including a Case of Oligocentric Disease by Beckham, Thomas H., Yang, Joanna C., Chau, Karen W., Noy, Ariela, Yahalom, Joachim

    Published in Clinical lymphoma, myeloma and leukemia (01-10-2020)
    “…Castleman disease (CD) is a rare polyclonal lymphoproliferative disorder of unclear etiology. Standard therapy for unicentric CD is surgical resection…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Renal Function Outcomes of High-risk Neuroblastoma Patients Undergoing Radiation Therapy by Beckham, Thomas H., Casey, Dana L., LaQuaglia, Michael P., Kushner, Brian H., Modak, Shakeel, Wolden, Suzanne L.

    “…To analyze the renal function outcomes in patients undergoing radiation therapy for neuroblastoma. The clinical metrics of renal function were analyzed in…”
    Get full text
    Journal Article